Dashboard
Manage Tickers

SLP


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/22/2025 17:06:27

winnebago-industries-travel--leisure-avery-dennison-hilton-worldwide-and-other-big-stocks-moving-higher-on-wednesday
Winnebago Industries, Travel + Leisure, Av...
10/22/2025 14:27:05

simulations-plus-sees-prelim-fy26-adj-eps-103110-revenue-79m-82m
Simulations Plus Sees Prelim. FY26 Adj. EP...
10/22/2025 11:54:02

deep-dive-into-simulations-plus-stock-analyst-perspectives-4-ratings
Deep Dive Into Simulations Plus Stock: Ana...
09/30/2025 20:01:13

td-cowen-initiates-coverage-on-simulations-plus-with-hold-rating-announces-price-target-of-16
TD Cowen Initiates Coverage On Simulations...
09/30/2025 15:16:46

TD Cowen analyst Brendan Smith initiates coverage on Simulations Plus (NASDAQ:SLP) with a Hold rating and announces Price Ta...

Core News & Articles
Noble Corporation, Q2 Holdings, Waystar Ho...
09/05/2025 21:49:59

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20250905-1479730/1479730_sept2025-1500rebalance.pdf 

simulations-plus-announces-publication-of-experimental-results-of-aidd-collaboration-with-imb-pas-in-acs-medical-chemistry-letters
Simulations Plus Announces Publication Of ...
07/29/2025 11:51:40

Researchers found 70% of compounds designed in ADMET Predictor demonstrated significant activity during in vitro testingSimulat...

simulations-plus-sees-weaker-demand-persist-outlook-softens
Simulations Plus Sees Weaker Demand Persis...
07/15/2025 17:56:28

Simulations Plus Inc. reported lower than expected sales and reduced guidance due to cautious biopharma spending.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/15/2025 17:06:53

Core News & Articles
Nasdaq Gains Over 100 Points; Wells Fargo ...
07/15/2025 16:06:04

simulations-plus-fb-financial-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
Simulations Plus, FB Financial And Other B...
07/15/2025 12:40:03

this-carrier-global-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday
This Carrier Global Analyst Is No Longer B...
07/15/2025 12:21:26

breaking-down-simulations-plus-4-analysts-share-their-views
Breaking Down Simulations Plus: 4 Analysts...
07/15/2025 12:00:35

stephens--co-maintains-overweight-on-simulations-plus-lowers-price-target-to-20
Stephens & Co. Maintains Overweight on Sim...
07/15/2025 12:00:10

Stephens & Co. analyst Jeff Garro maintains Simulations Plus (NASDAQ:SLP) with a Overweight and lowers the price target ...

why-trade-desk-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket
Why Trade Desk Shares Are Trading Higher B...
07/15/2025 11:24:36

keybanc-downgrades-simulations-plus-to-sector-weight
Keybanc Downgrades Simulations Plus to Sec...
07/15/2025 10:41:36

Keybanc analyst Scott Schoenhaus downgrades Simulations Plus (NASDAQ:SLP) from Overweight to Sector Weight.

simulations-plus-invests-1m-in-clinical-development-technology-company-nurocor
Simulations Plus Invests $1M In Clinical D...
07/14/2025 20:17:51

simulations-plus-lowers-fy2025-adj-eps-guidance-from-107-120-to-093-106-vs-032-est-affirms-fy2025-sales-guidance-of-76000m-80000m-vs-82968m-est
Simulations Plus Lowers FY2025 Adj EPS Gui...
07/14/2025 20:09:22

Simulations Plus (NASDAQ:SLP) lowers FY2025 Adj EPS guidance from $1.07-$1.20 to $0.93-$1.06 vs $0.32 analyst estimate. Affirms...

simulations-plus-q3-adj-eps-045-sales-20363m-miss-20878m-estimate
Simulations Plus Q3 Adj. EPS $0.45, Sales ...
07/14/2025 20:08:20

Simulations Plus (NASDAQ:SLP) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.07...

keybanc-maintains-overweight-on-simulations-plus-lowers-price-target-to-25
Keybanc Maintains Overweight on Simulation...
07/14/2025 12:40:02

Keybanc analyst Scott Schoenhaus maintains Simulations Plus (NASDAQ:SLP) with a Overweight and lowers the price target from ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION